BRPI0510397A - compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmos - Google Patents
compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmosInfo
- Publication number
- BRPI0510397A BRPI0510397A BRPI0510397-5A BRPI0510397A BRPI0510397A BR PI0510397 A BRPI0510397 A BR PI0510397A BR PI0510397 A BRPI0510397 A BR PI0510397A BR PI0510397 A BRPI0510397 A BR PI0510397A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- methods
- compositions containing
- pharmaceutical compositions
- same
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57463904P | 2004-05-26 | 2004-05-26 | |
| PCT/US2005/018443 WO2005117590A2 (en) | 2004-05-26 | 2005-05-25 | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0510397A true BRPI0510397A (pt) | 2007-11-13 |
Family
ID=35463277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0510397-5A BRPI0510397A (pt) | 2004-05-26 | 2005-05-25 | compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090005435A1 (https=) |
| EP (1) | EP1758577A4 (https=) |
| JP (1) | JP2008500363A (https=) |
| KR (1) | KR20070095754A (https=) |
| CN (1) | CN101022792A (https=) |
| AU (1) | AU2005249437A1 (https=) |
| BR (1) | BRPI0510397A (https=) |
| CA (1) | CA2568639A1 (https=) |
| IL (1) | IL179530A0 (https=) |
| MX (1) | MXPA06013687A (https=) |
| RU (1) | RU2006146051A (https=) |
| WO (1) | WO2005117590A2 (https=) |
| ZA (1) | ZA200700024B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007014248A2 (en) * | 2005-07-26 | 2007-02-01 | Johns Hopkins University | Method of reducing food intake |
| JP5489333B2 (ja) * | 2006-09-22 | 2014-05-14 | メルク・シャープ・アンド・ドーム・コーポレーション | 脂肪酸合成阻害剤を用いた治療の方法 |
| ES2660690T3 (es) * | 2007-10-05 | 2018-03-23 | Genzyme Corporation | Método para tratar poliquistosis renales con derivados de ceramida |
| WO2010118324A2 (en) | 2009-04-09 | 2010-10-14 | Nuclea Biotechnologies, LLC | Antibodies against fatty acid synthase |
| JP6285442B2 (ja) * | 2012-09-07 | 2018-02-28 | ヤンセン ファーマシューティカ エヌ．ベー． | がん治療用の脂肪酸合成酵素（ｆａｓｎ）阻害剤として有用なイミダゾリン−５−オン誘導体 |
| WO2016079317A1 (en) | 2014-11-20 | 2016-05-26 | Vib Vzw | Means and methods for treatment of early-onset parkinson's disease |
| MX2022009078A (es) | 2020-01-23 | 2022-08-15 | Basf Se | Formulaciones de ppo que contienen sulfatos de eter. |
| JP2023547434A (ja) | 2020-10-27 | 2023-11-10 | ビーエーエスエフ ソシエタス・ヨーロピア | 有害生物防除用マイクロエマルジョン組成物 |
| CR20230380A (es) | 2021-02-05 | 2023-10-12 | Basf Se | Composiciones herbicidas liquidas |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3427847A1 (de) * | 1983-12-09 | 1985-06-13 | Bayer Ag, 5090 Leverkusen | Thiolan-2,4-dion-3-carboxamide |
| US5759837A (en) * | 1989-01-17 | 1998-06-02 | John Hopkins University | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway |
| US5614551A (en) * | 1994-01-24 | 1997-03-25 | The Johns Hopkins University | Inhibitors of fatty acid synthesis as antimicrobial agents |
| US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
| EP1471906A4 (en) * | 2002-02-08 | 2006-02-01 | Univ Johns Hopkins Med | STIMULATION OF CPT-1 TO REDUCE BODY WEIGHT |
| EP2386551A1 (en) * | 2002-07-09 | 2011-11-16 | Fasgen Inc. | Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
-
2005
- 2005-05-25 CN CNA2005800233119A patent/CN101022792A/zh active Pending
- 2005-05-25 AU AU2005249437A patent/AU2005249437A1/en not_active Abandoned
- 2005-05-25 CA CA002568639A patent/CA2568639A1/en not_active Abandoned
- 2005-05-25 ZA ZA200700024A patent/ZA200700024B/en unknown
- 2005-05-25 MX MXPA06013687A patent/MXPA06013687A/es not_active Application Discontinuation
- 2005-05-25 US US11/597,538 patent/US20090005435A1/en not_active Abandoned
- 2005-05-25 JP JP2007515318A patent/JP2008500363A/ja active Pending
- 2005-05-25 BR BRPI0510397-5A patent/BRPI0510397A/pt not_active IP Right Cessation
- 2005-05-25 WO PCT/US2005/018443 patent/WO2005117590A2/en not_active Ceased
- 2005-05-25 EP EP05754100A patent/EP1758577A4/en not_active Withdrawn
- 2005-05-25 KR KR1020067026941A patent/KR20070095754A/ko not_active Withdrawn
- 2005-05-25 RU RU2006146051/04A patent/RU2006146051A/ru not_active Application Discontinuation
-
2006
- 2006-11-23 IL IL179530A patent/IL179530A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL179530A0 (en) | 2007-05-15 |
| WO2005117590A2 (en) | 2005-12-15 |
| ZA200700024B (en) | 2008-06-25 |
| JP2008500363A (ja) | 2008-01-10 |
| AU2005249437A1 (en) | 2005-12-15 |
| RU2006146051A (ru) | 2008-07-10 |
| EP1758577A4 (en) | 2010-05-05 |
| EP1758577A2 (en) | 2007-03-07 |
| US20090005435A1 (en) | 2009-01-01 |
| KR20070095754A (ko) | 2007-10-01 |
| CN101022792A (zh) | 2007-08-22 |
| WO2005117590A3 (en) | 2006-07-27 |
| CA2568639A1 (en) | 2005-12-15 |
| MXPA06013687A (es) | 2007-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0309534A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0512659A (pt) | compostos quìmicos | |
| AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
| BR0306150A (pt) | Composto, uso de um composto, e, composição farmacêutica | |
| BR0208678A (pt) | Composto, composição farmacêutica, uso de um composto | |
| EA201791254A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
| BRPI0507495A (pt) | composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
| BR9907300A (pt) | Inibidores do fator xa oxoaza-heterociclila substituìdos | |
| BR0010520A (pt) | Novos compostos farmaceuticamente ativos | |
| BRPI0412659A (pt) | isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto | |
| BR0008763A (pt) | Derivados de piridopiranoazepinas, a preparação dos mesmos e a respectiva aplicação em terapêutica | |
| BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
| BRPI0510397A (pt) | compostos, composições farmacêuticas contendo os mesmos, e métodos de uso dos mesmos | |
| ATE503746T1 (de) | Neue imidazolidinderivate | |
| ATE482933T1 (de) | Sulfopyrrolderivate | |
| DE60330758D1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| BR0100234A (pt) | Compostos de piperidina-4-sulfonamida, processo para a sua preparação e composições farmacêuticas contendo os mesmos | |
| BR0004534A (pt) | Composto, composição farmacêutica, agente contendo um composto, e uso de um composto. | |
| BR0213465A (pt) | Compostos de 4-imidazolin-2-ona | |
| BRPI0506718A (pt) | compostos, processo de preparação dos mesmos, e, composição farmacêutica ou cosmética | |
| BRPI0508102A (pt) | inibidores de caspase e usos dos mesmos | |
| BRPI0407386A (pt) | Derivados de álcool de amino, composições farmacêuticas contendo os mesmos e uso destes | |
| BRPI0812816B8 (pt) | compostos derivados de sulfonil-quinolina, ligantes com preferência para subtipo de receptor mglur1 e mglur5, processos para a preparação dos referidos compostos, formulação farmacêutica compreendedo os referidos compostos e uso dos mesmos | |
| NO973213L (no) | Nye 2-(1H)-quinolinforbindelser, fremgangsmåter ved fremstilling av slike samt farmasöytiske sammensetninger omfattende disse | |
| BRPI0417544A (pt) | compostos quìmicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |